For over a decade, the American Society of Clinical Oncology (ASCO) maintained CancerLinQ, a pioneering initiative designed...
Treatment Innovations
In a significant development for the field of interventional radiology and vascular surgery, Texas-based medical device manufacturer...
By Jonathan Gardner | Published August 13, 2026 The landscape for treating EGFR exon 20 insertion-mutated non-small...
In a significant transformation for the business-to-business (B2B) media landscape, Cleveland-based WTWH Media—the parent organization behind Drug...
In a significant stride toward addressing a common yet debilitating complication of abdominal surgery, Becton, Dickinson and...
In a landmark development for the HIV therapeutic landscape, pharmaceutical giants Gilead Sciences and Merck have unveiled...
In the rapidly accelerating landscape of pharmaceutical research, a narrative has taken hold: Artificial Intelligence (AI) is...
In a significant move aimed at addressing the critical shortage of viable donor organs, Illinois-based medical technology...
In a significant setback for its burgeoning cardiovascular portfolio, pharmaceutical giant Novo Nordisk announced that its investigational...
As Eli Lilly prepares for the high-stakes regulatory filing of its experimental weight-loss powerhouse, retatrutide—often dubbed the...
